Chuan An Biotechnology Co., Ltd.
Quick facts
Phase 2 pipeline
- CIK Cell · Oncology
CIK cells are a type of adoptive cell therapy that stimulate the immune system to attack cancer cells.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: